( en | de | ru )

 

Disambiguation of "Spalluto, G."

Author of the publication

copydeleteadd this publication to your clipboard
(3)HMRE 3008F20: a novel antagonist radioligand for the pharmacological and biochemical characterization of human A(3) adenosine receptors

, , , , , , , , , and . Mol Pharmacol, 57 (5): 968-75 (May 2000)Varani, K Merighi, S Gessi, S Klotz, K N Leung, E Baraldi, P G Cacciari, B Romagnoli, R Spalluto, G Borea, P A United states Molecular pharmacology Mol Pharmacol. 2000 May;57(5):968-75..

Please choose a person to relate this publication to

To differ between persons with the same name, the academic degree and the title of an important publication will be displayed. You can also use the button next to the name to display some publications already assigned to the person.

Giuseppe G G Manzardo

G Wahl

G Bol

G Seifert

G Hübner

 

Other publications of authors with the same name

Exploring potency and selectivity receptor antagonist profiles using a multilabel classification approach: the human adenosine receptors as a key study, , , , , , , , and . J Chem Inf Model, 49 (12): 2820-36 (December 2009)Michielan, Lisa Stephanie, Federico Terfloth, Lothar Hristozov, Dimitar Cacciari, Barbara Klotz, Karl-Norbert Spalluto, Giampiero Gasteiger, Johann Moro, Stefano Research Support, Non-U.S. Gov't United States Journal of chemical information and modeling J Chem Inf Model. 2009 Dec;49(12):2820-36..New 2,6,9-trisubstituted adenines as adenosine receptor antagonists: a preliminary SAR profile, , , , , , , and . Purinergic Signal, 3 (4): 339-46 (September 2007)Lambertucci, Catia Cristalli, Gloria Dal Ben, Diego Kachare, Dhuldeo D Bolcato, Chiara Klotz, Karl-Norbert Spalluto, Giampiero Volpini, Rosaria Netherlands Purinergic signalling Purinergic Signal. 2007 Sep;3(4):339-46. Epub 2007 Sep 19..Linear and nonlinear 3D-QSAR approaches in tandem with ligand-based homology modeling as a computational strategy to depict the pyrazolo-triazolo-pyrimidine antagonists binding site of the human adenosine A2A receptor, , , , , , , , , and . J Chem Inf Model, 48 (2): 350-63 (February 2008)Michielan, Lisa Bacilieri, Magdalena Schiesaro, Andrea Bolcato, Chiara Pastorin, Giorgia Spalluto, Giampiero Cacciari, Barbara Klotz, Karl Norbet Kaseda, Chosei Moro, Stefano Research Support, Non-U.S. Gov't United States Journal of chemical information and modeling J Chem Inf Model. 2008 Feb;48(2):350-63. Epub 2008 Jan 24..Synthesis, biological activity, and molecular modeling investigation of new pyrazolo4,3-e-1,2,4-triazolo1,5-cpyrimidine derivatives as human A(3) adenosine receptor antagonists, , , , , , , , , and . J Med Chem, 45 (4): 770-80 (February 2002)Baraldi, Pier Giovanni Cacciari, Barbara Moro, Stefano Spalluto, Giampiero Pastorin, Giorgia Da Ros, Tatiana Klotz, Karl-Norbert Varani, Katia Gessi, Stefania Borea, Pier Andrea Research Support, Non-U.S. Gov't United States Journal of medicinal chemistry J Med Chem. 2002 Feb 14;45(4):770-80..(3)HMRE 3008F20: a novel antagonist radioligand for the pharmacological and biochemical characterization of human A(3) adenosine receptors, , , , , , , , , and . Mol Pharmacol, 57 (5): 968-75 (May 2000)Varani, K Merighi, S Gessi, S Klotz, K N Leung, E Baraldi, P G Cacciari, B Romagnoli, R Spalluto, G Borea, P A United states Molecular pharmacology Mol Pharmacol. 2000 May;57(5):968-75..Synthesis, biological studies and molecular modeling investigation of 1,3-dimethyl-2,4-dioxo-6-methyl-8-(substituted) 1,2,3,4-tetrahydro 1,2,4-triazolo 3,4-f-purines as potential adenosine receptor antagonists, , , , , , , and . Farmaco, 60 (4): 299-306 (April 2005)Pastorin, Giorgia Bolcato, Chiara Cacciari, Barbara Kachler, Sonja Klotz, Karl-Norbert Montopoli, Christian Moro, Stefano Spalluto, Giampiero Research Support, Non-U.S. Gov't Italy Farmaco (Societa chimica italiana : 1989) Farmaco. 2005 Apr;60(4):299-306..Pyrazolo-triazolo-pyrimidines as adenosine receptor antagonists: A complete structure-activity profile, , , , , , and . Purinergic Signal, 3 (3): 183-93 (June 2007)Cacciari, Barbara Bolcato, Chiara Spalluto, Giampiero Klotz, Karl-Norbet Bacilieri, Magdalena Deflorian, Francesca Moro, Stefano Netherlands Purinergic signalling Purinergic Signal. 2007 Jun;3(3):183-93. Epub 2006 Nov 14..Pyrazolo-triazolo-pyrimidines as adenosine receptor antagonists: Effect of the N-5 bond type on the affinity and selectivity at the four adenosine receptor subtypes, , , , , , , and . Purinergic Signal, 4 (1): 39-46 (March 2008)Bolcato, Chiara Cusan, Claudia Pastorin, Giorgia Spalluto, Giampiero Cacciari, Barbara Klotz, Karl Norbert Morizzo, Erika Moro, Stefano Netherlands Purinergic signalling Purinergic Signal. 2008 Mar;4(1):39-46. Epub 2007 Jul 25..Pyrazolo4,3-e1,2,4-triazolo1,5-cpyrimidine derivatives as highly potent and selective human A(3) adenosine receptor antagonists: influence of the chain at the N(8) pyrazole nitrogen, , , , , , , , , and 1 other author(s). J Med Chem, 43 (25): 4768-80 (December 2000)Baraldi, P G Cacciari, B Romagnoli, R Spalluto, G Moro, S Klotz, K N Leung, E Varani, K Gessi, S Merighi, S Borea, P A Research Support, Non-U.S. Gov't United states Journal of medicinal chemistry J Med Chem. 2000 Dec 14;43(25):4768-80..Pyrazolo4,3-e-1,2,4-triazolo1,5-cpyrimidine derivatives as highly potent and selective human A(3) adenosine receptor antagonists, , , , , , , , , and . J Med Chem, 42 (22): 4473-8 (November 1999)Baraldi, P G Cacciari, B Romagnoli, R Spalluto, G Klotz, K N Leung, E Varani, K Gessi, S Merighi, S Borea, P A In Vitro Research Support, Non-U.S. Gov't United states Journal of medicinal chemistry J Med Chem. 1999 Nov 4;42(22):4473-8..